CSF2 and melanoma: In a Phase I clinical trial investigating the biologic activity of vaccination with irradiated autologous melanoma cells engineered to secrete human GM-CSF in patients with metastatic melanoma, it was demonstrated that immunization sites were intensely infiltrated with T lymphocytes and macrophages in all 21 evaluated patients and resulted in extensive tumor destruction [39].